Evidence map›Paper›PMID 31440584›Full record

ArticleJournal of cancer metastasis and treatment2019

Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.

Nathaniel J Robinson, Derek J Taylor, William P Schiemann

Abstract read
In one paragraph

Article in Journal of cancer metastasis and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Introduction to this special issue "Breast Cancer Metastasis".Journal of cancer metastasis and treatment · 2020
    Article
  11. TGF-β Signaling in Cellular Senescence and Aging-Related Pathology.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nathaniel J RobinsonDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Derek J TaylorDepartment of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
William P SchiemannCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106 USA.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Clinical and Translational Science Collaborative of ClevelandTL1TR000441 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$2.8M
Induction of cancer cell death by selective DNA misincorporationDP2CA186571 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TAYLOR, DEREK JAMES · 2013 to 2014
$2.6M
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and RecurrenceR01CA236273 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SCHIEMANN, WILLIAM, VALADKHAN, SABA · 2019 to 2023
$2.3M
Molecular interactions and regulatory events of telomere proteinsR01GM133841 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI TAYLOR, DEREK JAMES · 2019 to 2022
$1.7M
SLX4IP and a novel regulatory network in breast cancer metastasis and dormancyF30CA213892 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ROBINSON, NATHANIEL JAMES · 2017 to 2020
$166k
NCATS NIH HHS TL1 TR000441NCATS NIH HHS TL1 TR002549NCI NIH HHS DP2 CA186571NCI NIH HHS F30 CA213892NCI NIH HHS R01 CA236273NIGMS NIH HHS R01 GM133841NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Breast cancer is the most significant cause of cancer-related death in women around the world. The vast majority of breast cancer-associated mortality stems from metastasis, which remains an incurable disease state. Metastasis results from evolution of clones that possess the insidious properties required for dissemination and colonization of distant organs. These clonal populations are descended from breast cancer stem cells (CSCs), which are also responsible for their prolonged maintenance and continued evolution. Telomeres impose a lifespan on cells that can be extended when they are actively elongated, as occurs in CSCs. Thus, changes in telomere structure serve to promote the survival of CSCs and subsequent metastatic evolution. The selection of telomere maintenance mechanism (TMM) has important consequences not only for CSC survival and evolution, but also for their coordination of various signaling pathways that choreograph the metastatic cascade. Targeting the telomere maintenance machinery may therefore provide a boon to the treatment of metastatic breast cancer. Here we review the two major TMMs and the roles they play in the development of stem and metastatic breast cancer cells. We also highlight current and future approaches to targeting these mechanisms in clinical settings to alleviate metastatic breast cancers.

Indexed as

breast cancercancer evolutioncancer stem cellsmetastasistelomerase

Identifiers

PMID31440584
PMCPMC6706062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.